NCT07483827: A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy

Sponsor: eleva GmbH. Phase: PHASE1. Conditions: C3 Glomerulopathy (C3G), Healthy Adult Participants